Dogwood Therapeutics, Inc. financial data

Symbol
DWTX on Nasdaq
Location
44 Milton Avenue, Alpharetta, GA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 606 % +25.8%
Debt-to-equity 658 % +2412%
Return On Equity -1.38K % -534%
Return On Assets -40.2 % +76.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.29M shares +72.1%
Common Stock, Shares, Outstanding 2.29M shares +107%
Entity Public Float 5.76M USD -76.4%
Common Stock, Value, Issued 229 USD +106%
Weighted Average Number of Shares Outstanding, Basic 1.92M shares +72.9%
Weighted Average Number of Shares Outstanding, Diluted 1.92M shares +72.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 21.8M USD +1343%
General and Administrative Expense 9.86M USD +129%
Operating Income (Loss) -31.7M USD -444%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -38M USD -564%
Net Income (Loss) Attributable to Parent -38.2M USD -567%
Earnings Per Share, Basic -26 USD/shares -159%
Earnings Per Share, Diluted -26 USD/shares -159%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.1M USD +396%
Assets, Current 11.7M USD +410%
Property, Plant and Equipment, Net 15.3K USD
Operating Lease, Right-of-Use Asset 174K USD
Intangible Assets, Net (Excluding Goodwill) 67.9M USD
Goodwill 12.2M USD
Assets 92M USD +3929%
Accounts Payable, Current 585K USD +28.5%
Employee-related Liabilities, Current 597K USD
Accrued Liabilities, Current 1.96M USD +123%
Liabilities, Current 2.6M USD +94.7%
Deferred Income Tax Liabilities, Net 11.9M USD
Operating Lease, Liability, Noncurrent 120K USD
Other Liabilities, Noncurrent 15.4M USD
Liabilities 14.6M USD +995%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.64M USD
Retained Earnings (Accumulated Deficit) -104M USD -57.8%
Stockholders' Equity Attributable to Parent 7.26M USD +664%
Liabilities and Equity 92M USD +3929%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.68M USD -400%
Net Cash Provided by (Used in) Financing Activities 7.37M USD
Common Stock, Shares Authorized 43M shares 0%
Common Stock, Shares, Issued 2.3M shares +106%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.1M USD +396%
Deferred Tax Assets, Valuation Allowance 31.4M USD +216%
Deferred Tax Assets, Gross 38.3M USD +277%
Operating Lease, Liability 175K USD
Depreciation 17K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -39.8M USD -650%
Lessee, Operating Lease, Liability, to be Paid 194K USD
Property, Plant and Equipment, Gross 19K USD
Operating Lease, Liability, Current 54.6K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 67.2K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 66K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Deferred Income Tax Expense (Benefit) 189K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19.6K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 43.2K USD
Deferred Tax Assets, Operating Loss Carryforwards 26.1M USD +266%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares -0.11%
Lessee, Operating Lease, Liability, to be Paid, Year Four 41.8K USD
Operating Lease, Payments 121K USD
Additional Paid in Capital 73.2M USD +8.64%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 6.9M USD +3102%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%